The Massachusetts law permitting pharmacies and pharmaceutical manufacturers to offer drug discounts to patients, which was set to expire on January 1, 2023, has recently been extended to January 1, 2026. In its current form, Mass. Gen. Laws Ann. ch. 175H, § 3 allows pharmacies to provide discounts to patients. It also allows pharmaceutical manufacturers to provide discounts, rebates, product vouchers, and other price reductions for individuals’ out-of-pocket drug expenses. The initial version of the law, passed in 2012, contained a sunset provision for 2015. This date has been extended six times, including the most recent extension.
Massachusetts lawmakers are currently considering a bill to open up health screenings across the state. This bill, S 2567, would establish a statewide protocol for pharmacists to test or screen (and initiate treatment) for qualified health conditions, like influenza, COVID-19, and HIV. In effect, S 2567 would allow pharmacies to obtain CLIA waivers to expand on the types of health screening tests they currently offer. Then, it would allow pharmacists to administer, process, read and report the results, and treat conditions with appropriate therapies. S 2567 is in the early stages of its development and is expected to be heard by the House and Senate soon.
The state of Massachusetts ruled that all prescriptions for controlled substances and medical devices must be issued electronically, with only a few exceptions. ePrescribing allows for greater patient oversight from both physicians pharmacists and minimizes the risk of substance abuse. The law went into effect on January 1, 2021.